HomeNASDAQ:MRNA

NASDAQ:MRNA

Moderna Expands AI Efforts: Is the Stock Worth Buying?

Moderna Expands AI Efforts: Is the Stock Worth Buying?

May 22, 2024

Moderna Beats Q1 Loss Expectations, Stock Surges on RSV and Spikevax Plans

Moderna Beats Q1 Loss Expectations, Stock Surges on RSV and Spikevax Plans

May 3, 2024

Moderna Stock Surges After Oppenheimer Upgrade

Moderna Stock Surges After Oppenheimer Upgrade

January 3, 2024

Moderna Forecasts $4 Billion in 2023 Sales from Private Market for COVID-19 Shots

Moderna Forecasts $4 Billion in 2023 Sales from Private Market for COVID-19 Shots

August 3, 2023

Moderna Stock: Take Advantage of Weakness

Moderna Stock: Take Advantage of Weakness

June 13, 2023

Moderna Stock Falls as Flu Vaccine Misses Early Success Criteria; Study Continues

Moderna Stock Falls as Flu Vaccine Misses Early Success Criteria; Study Continues

April 11, 2023

Moderna Stock Fell After CEO Bancel Told Lawmakers COVID Vaccination Price Rises Are Justified

Moderna Stock Fell After CEO Bancel Told Lawmakers COVID Vaccination Price Rises Are Justified

March 22, 2023

Moderna Stock Rises as Cowen Upgrades Due to a Positive Catalyst Path

Moderna Stock Rises as Cowen Upgrades Due to a Positive Catalyst Path

March 13, 2023

Moderna Stock Gains on Positive Data From the Phase III RSV Jab Study

Moderna Stock Gains on Positive Data From the Phase III RSV Jab Study

January 18, 2023

Moderna Stock Drops as Secures Ebola Vaccine Contract With the U.S

Moderna Stock Drops as Secures Ebola Vaccine Contract With the U.S

January 11, 2023

1 2 3 »